Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.

Detailed Quote for AbbVie Inc. (ABBV)

Detailed Quote for AbbVie Inc. (ABBV)

Sector News | Topic News
News for AbbVie Inc. (ABBV)
Sat, May 25, 2019
8:01 AM 5 Safe And Cheap Dividend Stocks To Invest (May 2019) - SeekingAlpha
Fri, May 24, 2019
2:41 PM The Retiree's Dividend Portfolio - Jane's April Update: Why You Should Consider Canadian Banks - SeekingAlpha
Thu, May 23, 2019
8:53 PM Dividend Aristocrats Bustin' Out For June - SeekingAlpha
9:00 AM AbbVie reaches an agreement with the pan-Canadian Pharmaceutical Alliance (pCPA) for VENCLEXTA\u00AE, a treatment for chronic lymphocytic leukemia (CLL) - Canada Newswire
7:00 AM My Top 3 Companies Paving The Way For Medicinal Cannabis Research - SeekingAlpha
Tue, May 21, 2019
2:30 PM Pfizer: Added Value For A Defensive Pharma Portfolio - SeekingAlpha
8:29 AM AbbVie launches higher dose Orilissa - SeekingAlpha
8:00 AM AbbVie Launches ORILISSA(TM) (elagolix) 200 mg BID Dose for the Treatment of Moderate to Severe Pain Associated with Endometriosis - Canada Newswire
Mon, May 20, 2019
7:36 AM Takeda's Entyvio beats Humira in head-to-head UC study - SeekingAlpha
Sat, May 18, 2019
1:59 PM Enanta And EDP-305 In NASH: An Update - SeekingAlpha
Fri, May 17, 2019
9:11 AM AbbVie antibody-drug conjugate flunks late-stage brain cancer study; shares down 2% premarket - SeekingAlpha
8:45 AM AbbVie Provides Update on Depatuxizumab Mafodotin (Depatux-M), an Investigational Medicine for Newly Diagnosed Glioblastoma, an Aggressive Form of Brain Cancer - PR Newswire
Thu, May 16, 2019
10:34 AM AbbVie Grabs FDA Approval In HCV, Faces Several Risks - SeekingAlpha
Wed, May 15, 2019
3:21 PM FDA OKs expanded label for AbbVie and Roche's Venclexta - SeekingAlpha
2:19 PM AbbVie Announces US FDA Approval of VENCLEXTA\u00AE (venetoclax) as a Chemotherapy-Free Combination Regimen for Previously Untreated Chronic Lymphocytic Leukemia Patients - PR Newswire
7:42 AM Dogcatcher's Safety Check Of 21 Stocks In Kiplinger/Barron's Dividend Elite For May - SeekingAlpha
Tue, May 14, 2019
9:20 PM AbbVie Is Undervalued - SeekingAlpha
10:13 AM MC10, Inc. and AbbVie (NYSE:ABBV) Announce Clinical Trials in Multiple Sclerosis Using the BioStamp nPoint\u00AE\u00A0System - Business Wire
8:34 AM AbbVie Resolves HUMIRA\u00AE (adalimumab) U.S. Patent Litigation with Boehringer Ingelheim - PR Newswire
8:00 AM AbbVie to Present at the UBS Global Healthcare Conference - PR Newswire
More News for ABBV >>